Study guide

6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport

Neonatal Pediatric Transport C-NPT

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The C-NPT Exam

About the C-NPT Exam: 2026 Format, Eligibility & Content Outline

2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues

1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations

3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment

2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning

4 Chapter 3: Flight Physiology & Environmental Stressors

3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit

5 Chapter 4: Invasive Procedures & Transport Monitoring

4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines

6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation

5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting

7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes

6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies

8 Chapter 7: Neonatal Respiratory Pathologies & Management

7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure

9 Chapter 8: Neonatal Cardiovascular Critical Care

8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure

10 Chapter 9: Neonatal Neurological & Metabolic Crises

9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care

10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect

12 Chapter 11: Pediatric Respiratory Emergencies

11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

13 Chapter 12: Pediatric Shock & Cardiovascular Crises

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass

14 Chapter 13: Pediatric Neurological Emergencies & Trauma

13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness

15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies

14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures

16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies

15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport

Key Takeaways Explain This Topic AI

In pediatric septic shock, the Surviving Sepsis Campaign recommends starting broad-spectrum antimicrobials as soon as possible, within 1 hour of recognition; blood cultures should not delay the first dose.

Early-onset neonatal sepsis is treated empirically with ampicillin plus gentamicin; ampicillin covers Listeria and enterococci, which cephalosporins do not.

Cefotaxime has not been marketed in the United States since 2018, so ceftazidime or cefepime is used when a neonate needs a third- or fourth-generation cephalosporin (for example, suspected gram-negative meningitis).

Ceftriaxone is avoided in hyperbilirubinemic neonates and must not be given to neonates ≤28 days old who are receiving IV calcium-containing solutions.

Aminoglycosides cause nephrotoxicity and ototoxicity and can potentiate neuromuscular blockade; vancomycin should be infused over at least 60 minutes to prevent infusion (flushing) reactions.

Last updated: September 2026

Antimicrobial Pharmacology in Transport

Infection underlies many transport referrals: neonatal sepsis, meningitis, pneumonia, NEC, and pediatric septic shock. Transport teams often give the first antibiotic dose , so they must know which drugs to give, how fast, and what can go wrong.

Timing: The First Dose Should Not Wait for Transport

Septic shock: The Surviving Sepsis Campaign pediatric guidelines (2020) recommend broad-spectrum antimicrobials as soon as possible, within 1 hour of recognizing septic shock.

Probable sepsis without shock: Start as soon as possible, within 3 hours of recognition after appropriate evaluation.

Cultures: Draw blood cultures before antibiotics if doing so does not delay the dose . A lumbar puncture that cannot be done safely or quickly (Section 13.1) is deferred, and antibiotics are given anyway.

Documentation: Record the exact time of every dose so the receiving team can schedule the next dose and interpret cultures.

Empiric Regimens by Age and Syndrome

Situation Usual empiric choice Why

Early-onset neonatal sepsis (first 72 hours; GBS, E. coli ) Ampicillin + gentamicin Ampicillin covers group B strep, Listeria , and enterococci. Gentamicin covers gram-negative rods.

Neonatal meningitis suspected Meningitic-dose ampicillin + an extended-spectrum cephalosporin (ceftazidime or cefepime in the U.S.) ± gentamicin Better CSF penetration against gram-negatives

Late-onset neonatal sepsis (after 72 hours, often NICU-acquired) Vancomycin + gentamicin or an antipseudomonal cephalosporin, per unit patterns Coagulase-negative staph, S. aureus , resistant gram-negatives

Neonatal HSV risk (vesicles, seizures, maternal lesions, elevated transaminases, CSF pleocytosis) Add acyclovir 20 mg/kg IV every 8 hours Neonatal HSV is lethal without early treatment

Febrile infant 29–60 days with suspected meningitis Ceftriaxone + vancomycin S. pneumoniae and resistant strains

Child with septic shock Ceftriaxone (or cefepime/piperacillin-tazobactam if hospital-acquired or neutropenic) + vancomycin ; add clindamycin for suspected toxic shock Broad coverage; clindamycin suppresses toxin production

Pediatric bacterial meningitis Ceftriaxone + vancomycin (± acyclovir for encephalitis) Resistant pneumococcus

Necrotizing enterocolitis Ampicillin + gentamicin + anaerobic coverage (metronidazole or clindamycin), or per unit protocol Enteric gram-negatives and anaerobes

The cefotaxime problem: Cefotaxime was the preferred neonatal cephalosporin, but U.S. manufacturers stopped marketing it in 2018. The American Academy of Pediatrics lists ceftazidime as an alternative with similar enteric gram-negative coverage, and many units use cefepime . Older references and some exam items may still mention cefotaxime.

  • Drug-Specific Hazards Every Transport Clinician Must Know
  • Aminoglycosides (gentamicin, tobramycin)

Concentration-dependent killing: Extended-interval dosing (for example, every 24–48 hours in neonates, depending on gestational and postnatal age) gives high peaks and allows troughs to fall.

Toxicity: Nephrotoxicity and ototoxicity (vestibular and cochlear). Risk rises with high troughs, prolonged courses, and co-administered nephrotoxins or loop diuretics. Noise exposure during transport adds to cochlear stress in infants receiving aminoglycosides (Section 3.3).

Neuromuscular blockade: Aminoglycosides can potentiate paralytics and magnesium. Consider this when a newborn whose mother received magnesium sulfate is weak or apneic after intubation.

Levels: Hand off the timing of doses and any levels drawn.

Vancomycin

Infuse over at least 60 minutes . Rapid infusion causes the vancomycin infusion reaction (flushing, pruritus, and hypotension, historically called "red man syndrome"). It is histamine release, not true allergy; slow the infusion and give an antihistamine.

Nephrotoxicity rises with high exposure and some drug combinations. Many centers now dose by area under the curve (AUC) rather than trough targets alone.

Ceftriaxone in neonates

Hyperbilirubinemia: Ceftriaxone displaces bilirubin from albumin and can raise the free bilirubin available to cross into the brain. Avoid it in jaundiced neonates.

Calcium precipitates: Ceftriaxone-calcium precipitates have caused fatal lung and kidney deposits in neonates. The FDA states that ceftriaxone must not be given to neonates ≤28 days old who are receiving (or expected to receive) IV calcium-containing solutions, including parenteral nutrition.

Ampicillin

Covers Listeria and Enterococcus . Cephalosporins do not, which is why ampicillin remains part of neonatal and young-infant regimens.

Meningitic dosing is much higher than sepsis dosing. Confirm the indication with medical control.

Clindamycin and metronidazole

Clindamycin covers gram-positive organisms and some anaerobes, and it suppresses exotoxin production in toxic shock and necrotizing soft-tissue infection.

Metronidazole covers anaerobes ( Bacteroides , Clostridium species) in intra-abdominal infection and NEC.

Allergy considerations

Cross-reactivity between penicillin allergy and third-generation cephalosporins is low. A history of a remote rash rarely justifies withholding a cephalosporin in septic shock. A history of anaphylaxis should prompt medical-control discussion.

Administration in the Transport Environment

Compatibility: Many antibiotics are incompatible with other infusions. Use a dedicated line or flush between drugs, and never run antibiotics through a vasoactive line (Section 6.1).

Volume: In small infants, the dilution volume of several antibiotics can add up to a meaningful fluid load. Include it in the fluid totals.

Reconstitution in motion: Prepare doses before departure when possible, and use weight-based dosing references and a second-person check.

Monitoring: Watch for anaphylaxis (Section 12.2), infusion reactions, and extravasation.

Stewardship: Broad empiric coverage is correct in transport, but the handoff should include culture sources and times so the receiving team can narrow therapy.

Transport Scenario

A 10-day-old term infant arrives at a community ED with fever, lethargy, a bulging fontanelle, and a focal seizure. Blood cultures are drawn. The team defers the lumbar puncture because of instability and gives ampicillin at meningitic dosing, ceftazidime, and acyclovir 20 mg/kg (the mother reports a genital lesion at delivery). Ceftriaxone is avoided because the infant is jaundiced and may need calcium. The team hands off exact dose times, the pending cultures, and the HSV history to the receiving NICU.